IFNG and myeloid sarcoma: Our findings also illustrate the implications of long-term exposure to even very low concentrations of IFNγ, and highlight the importance of evaluating both cytoprotective and remyelination-promoting agents in the context of an inflammatory microenvironment that may influence repair in people with MS.